CIDRAP newsletters options
Eight more cases were reported by the South Carolina Department of Public Health today.
The onset of several conditions, including allergic rhinitis, viral infections, and ear infections, was also delayed after COVID-19 vaccination.
Data from a phase 4 study shows the RTS,S vaccine reduced malaria by 30% and severe malaria by 58% in young children in Ghana, Malawi, and Kenya.
At eight months of follow-up, Jynneos recipients not vaccinated against smallpox had lower binding antibody concentrations than those with infection.
At three months, relative to controls, greater improvements in intervention recipients were also seen for depression and anxiety and handgrip strength.
In the past 30 days officials have confirmed highly pathogenic avian flu in 31 commercial flocks and 31 backyard flocks across the United States.
Nashville also reported its first measles case in 20 years.
High-level tetracycline resistance and reduced susceptibility to cefixime was found in gonorrhea bacteria from doxyPEP users.
Canada had eliminated measles in 1998, 2 years prior to the United States.
Few reviews accounted for study quality, appropriately controlled for relevant confounders, or rigorously ascertained drug use and outcomes when interpreting the evidence, the authors say.
Infants in 10 states have been sickened, and all required hospitalization.
Trial investigators say the results could expand the scale and impact of mass drug administration campaigns against neglected tropical diseases.
The findings have implications for scheduling repeat dosing in eligible children, the authors say.
The rVSVΔG-LASV-GPC vaccine caused no serious adverse events and produced a strong immune response in healthy adults in the US and Liberia.
In Michigan, 113,000 birds were affected on a turkey farm in Ottawa County, the state's third detection in commercial turkeys in less than a week.
Texas health officials say the state has a seen a fourfold increase in whooping cough cases compared with last year.
The review will look at decades of data on the safety, efficacy, and public health impact of administering the hepatitis B shot at birth.
High-dose vaccine was 40% more effective against hospitalization than the standard-dose version.
Even without a booster, the vaccine triggered mucosal and systemic immunity, which other intranasal recombinant H5 flu vaccines have not achieved in clinical trials.
All but 46 of the confirmed cases have been in Senegal.
